For 25 years medical investigators have been working to find possible ways to better understand the pathological mechanisms underlying scleroderma. Their main objective is to improve treatment and hasten diagnosis. Early detection and treatment may prevent symptoms from worsening. Much progress has been made in the last 25 years, particularly regarding the mechanisms leading to fibrosis and damaged blood vessels. Thanks to these advances, there has been a steady increase in recent years in the success rate of treatments aimed at reducing disease-related manifestations and relieving pain. Despite all this, it is still impossible to eradicate scleroderma.
That is why financial support is so crucial for the continuation of research in scleroderma. Funding and advocacy by SABC have allowed the creation of the Scleroderma Clinic at St. Paul’s Hospital, purchase of necessary investigative equipment, support for the scleroderma-patient-centered-intervention-network (SPIN) and assistance for the only Scleroderma Research Chair in Canada. SABC funds and co-leads the Scleroderma Association of BC Research Project that is investigating miRNA sequences to potentially lead to improved diagnostic and treatment options.